Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock face investor scrutiny as RFK Jr. takes the leadership of HHS. Read more ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli Lilly seems to ... sending Lilly’s stock down about 6.5% on the day of the announcement. Lilly’s CEO, David ...

Eli Lilly and Co. shares climbed about 2% Thursday morning to $857.40 while broader trading indexes started the day mixed. Lilly's stock has already climbed 9% so far this year, as of Wednesday.

2024 was an interesting year for pharmaceutical powerhouse Eli ... Lilly investors haven't had much to celebrate so far in 2025. On Jan. 14, shares of Lilly dropped by as much as 8% and ended the ...

On January 14th, Eli Lilly (NYSE:LLY) released updated revenue guidance for Q4 FY24, with a $400 million reduction from the previously issued forecast. The stock dropped over 8% that day ...